Advertisement

Medical device company C8 MediSensors lands CE Mark approval for its optical glucose monitor system, a new non-invasive continuous glucose monitor.

C8 MediSensors logo

San Jose, Calif.-based C8 MediSensors received European CE Mark approval to launch its optical glucose monitoring system for diabetic patients.

The new non-invasive continuous glucose monitor features light spectroscopy that measures blood glucose levels without the need for frequent finger pricks.

Advertisement
Advertisement